Duspatal and Drowsiness - a phase IV clinical study of FDA data

Summary:

Drowsiness is reported as a side effect among people who take Duspatal (mebeverine hydrochloride), especially for people who are female, 60+ old, also take Celebrex, and have Pain.

The phase IV clinical study analyzes which people have Drowsiness when taking Duspatal. It is created by eHealthMe based on reports of 507 people who have side effects when taking Duspatal from the FDA, and is updated regularly.

What is Duspatal?

Duspatal has active ingredients of mebeverine hydrochloride. eHealthMe is studying from 540 Duspatal users. Check the latest studies of Duspatal.

What is Drowsiness?

Drowsiness is found to be associated with 2,866 drugs and 4,797 conditions by eHealthMe. Check the latest studies of Drowsiness.

On Jul, 17, 2026

507 people reported to have side effects when taking Duspatal.
Among them, 30 people (5.92%) have Drowsiness.

Among these 30 people:

What is the gender of people who have Drowsiness when taking Duspatal? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Drowsiness when taking Duspatal? *

What are other drugs people take besides Duspatal? *

What are other side effects people have besides Drowsiness? *

High Blood Pressure: 24 people, 80.00%
Joint Pain: 23 people, 76.67%
Headache (pain in head): 23 people, 76.67%
Stress And Anxiety: 22 people, 73.33%
Back Pain: 21 people, 70.00%
Fatigue (feeling of tiredness): 21 people, 70.00%
Pain: 21 people, 70.00%
Pain In Extremity: 20 people, 66.67%
Peripheral Swelling: 20 people, 66.67%
Gait Disturbance: 19 people, 63.33%

What are the existing conditions these people have? *

Pain: 19 people, 63.33%
Fibromyalgia (a long-term condition which causes pain all over the body): 17 people, 56.67%
Myosclerosis (hardening of muscle tissue): 16 people, 53.33%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 8 people, 26.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 26.67%
Gastritis - Chronic (long lasting inflammation of stomach): 8 people, 26.67%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 10.00%
Gastritis (inflammation of stomach): 3 people, 10.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 10.00%
Functional Gastrointestinal Disorder (functional problem in separate organs of gastrointestinal system): 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Duspatal and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Duspatal:

Duspatal (540 reports)

Drowsiness treatments and more:

Drowsiness (269,040 reports)

Browse all side effects of Duspatal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drowsiness:

Drowsiness (2,866 drugs)

Browse all the conditions that are associated with Drowsiness:

Drowsiness (4,797 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mebeverine hydrochloride (the active ingredients of Duspatal) and Duspatal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.